Home
NeuroRestore

NeuroRestore Market Share Analysis for April 2026

Friedli L, Rosenzweig ES, Barraud Q, Schubert M, Dominici N, Awai L, Nielson JL, Musienko P, Nout-Lomas Y, Zhong H, Zdunowski S, Roy RR, Strand SC, van den Brand R, Havton LA, Beattie MS, Bresnahan JC, Bézard E, Bloch J, Edgerton VR, Ferguson AR, Curt A, Tuszynski MH, Courtine G

Industry: N/A

Domainneurorestore.swiss

Year Founded2018

Employees51 - 200

Annual Revenue--

NeuroRestore

NeuroRestore (including company regionals)

neurorestore.swiss

See more website traffic and engagement information

Total visits to NeuroRestore's top domains

Understand NeuroRestore market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neurorestore.swiss6.5K

See more with Sales Intelligence

Avg. visit duration in NeuroRestore's top domains

Analyze NeuroRestore engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neurorestore.swiss00:00:12

See more with Sales Intelligence

Avg. pageviews on NeuroRestore's top domains

See how NeuroRestore keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neurorestore.swiss1.76

See more with Sales Intelligence

NeuroRestore top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by NeuroRestore

These are the website technologies, by industry, used by NeuroRestore top domains

Conversion & Analytics (4)

Google Analytics

Payment & Currencies (4)

Cart Functionality

Advertising (3)

Google Adsense

Audio Video Media (2)

YouTube

More Technologies

8

See all

News & Signals from NeuroRestore

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeuroRestore receives financing of $1M in grant.NeuroRestore was awarded a $1 million grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to implant the ARC-IM System and investigate the effect of ARC Therapy in six additional participants with Parkinson's disease.